{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T10:51:48Z","timestamp":1790247108329,"version":"4.1.0"},"reference-count":75,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2013,12,1]],"date-time":"2013-12-01T00:00:00Z","timestamp":1385856000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2013,12,1]],"date-time":"2013-12-01T00:00:00Z","timestamp":1385856000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","journal.chestnet.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Chest"],"published-print":{"date-parts":[[2013,12]]},"DOI":"10.1378\/chest.13-0382","type":"journal-article","created":{"date-parts":[[2013,12,3]],"date-time":"2013-12-03T03:30:49Z","timestamp":1386041449000},"page":"1937-1945","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":17,"title":["Octreotide"],"prefix":"10.1016","volume":"144","author":[{"given":"Mallory M.","family":"Chan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael M.","family":"Chan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John Andrew","family":"Mengshol","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Douglas N.","family":"Fish","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edward D.","family":"Chan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"10","key":"10.1378\/chest.13-0382_bib1","doi-asserted-by":"crossref","first-page":"1326","DOI":"10.1093\/rheumatology\/keh720","article-title":"Painful hypertrophic osteoarthropathy successfully treated with octreotide. The pathogenetic role of vascular endothelial growth factor (VEGF)","volume":"44","author":"Angel-Moreno Maroto","year":"2005","journal-title":"Rheumatology (Oxford)"},{"issue":"3","key":"10.1378\/chest.13-0382_bib2","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1002\/cncr.26200","article-title":"Diffuse idiopathic pulmonary neuroendocrine cell hyperplasia and the associated lung neuroendocrine tumors: clinical experience with a rare entity","volume":"118","author":"Gorshtein","year":"2012","journal-title":"Cancer"},{"issue":"suppl 2","key":"10.1378\/chest.13-0382_bib3","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1159\/000051474","article-title":"Somatostatin and octreotide: physiological background and pharmacological application","volume":"60","author":"Beglinger","year":"1999","journal-title":"Digestion"},{"key":"10.1378\/chest.13-0382_bib4","series-title":"Williams Textbook of Endocrinology","first-page":"85","article-title":"Neuroendocrinology","author":"Low","year":"2008"},{"key":"10.1378\/chest.13-0382_bib5","series-title":"Williams Textbook of Endocrinology","first-page":"1821","article-title":"Carcinoid tumors, the carcinoid syndrome, and related disorders","author":"Obery","year":"2008"},{"issue":"3","key":"10.1378\/chest.13-0382_bib6","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1006\/frne.1999.0183","article-title":"Somatostatin and its receptor family","volume":"20","author":"Patel","year":"1999","journal-title":"Front Neuroendocrinol"},{"key":"10.1378\/chest.13-0382_bib7","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1196\/annals.1294.012","article-title":"Molecular signaling of somatostatin receptors","volume":"1014","author":"Lahlou","year":"2004","journal-title":"Ann N Y Acad Sci"},{"issue":"3","key":"10.1378\/chest.13-0382_bib8","doi-asserted-by":"crossref","first-page":"1347","DOI":"10.1152\/jn.00098.2010","article-title":"Modulation of voltage-gated ion channels in rat retinal ganglion cells mediated by somatostatin receptor subtype 4","volume":"104","author":"Farrell","year":"2010","journal-title":"J Neurophysiol"},{"issue":"6","key":"10.1378\/chest.13-0382_bib9","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1111\/j.1478-3231.2007.01503.x","article-title":"Expression of somatostatin receptors in splanchnic blood vessels of normal and cirrhotic rats","volume":"27","author":"Reynaert","year":"2007","journal-title":"Liver Int"},{"issue":"3","key":"10.1378\/chest.13-0382_bib10","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1248\/bpb.17.415","article-title":"Inhibitory action of somatostatin on cAMP dependent pepsinogen secretion from rat gastric chief cells: involvement of pertussis toxin-sensitive G-protein","volume":"17","author":"Tanaka","year":"1994","journal-title":"Biol Pharm Bull"},{"issue":"4","key":"10.1378\/chest.13-0382_bib11","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1007\/s00726-005-0289-3","article-title":"Strategies to improve plasma half life time of peptide and protein drugs","volume":"30","author":"Werle","year":"2006","journal-title":"Amino Acids"},{"issue":"6","key":"10.1378\/chest.13-0382_bib12","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1517\/14740330903379525","article-title":"Octreotide LAR: safety and tolerability issues","volume":"8","author":"Bornschein","year":"2009","journal-title":"Expert Opin Drug Saf"},{"key":"10.1378\/chest.13-0382_bib13","series-title":"Sandostatin LAR Depot (octreotide acetate long-acting) [package insert]","year":"2012"},{"issue":"8","key":"10.1378\/chest.13-0382_bib14","doi-asserted-by":"crossref","first-page":"904","DOI":"10.1111\/j.1365-2036.2012.05050.x","article-title":"Randomised clinical trial: the safety and efficacy of long-acting octreotide in patients with portal hypertension","volume":"35","author":"Chandok","year":"2012","journal-title":"Aliment Pharmacol Ther"},{"issue":"4","key":"10.1378\/chest.13-0382_bib15","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1056\/NEJM199601253340408","article-title":"Octreotide","volume":"334","author":"Lamberts","year":"1996","journal-title":"N Engl J Med"},{"issue":"10","key":"10.1378\/chest.13-0382_bib16","first-page":"4127","article-title":"High-dose octreotide acetate for management of gastroenteropancreatic neuroendocrine tumors","volume":"29","author":"Chadha","year":"2009","journal-title":"Anticancer Res"},{"issue":"8","key":"10.1378\/chest.13-0382_bib17","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/S0026-0495(96)90087-6","article-title":"Sandostatin LAR: a promising therapeutic tool in the management of acromegalic patients","volume":"45","author":"Lancranjan","year":"1996","journal-title":"Metabolism"},{"issue":"10","key":"10.1378\/chest.13-0382_bib18","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1007\/s12325-011-0062-9","article-title":"Safety review: dose optimization of somatostatin analogs in patients with acromegaly and neuroendocrine tumors","volume":"28","author":"Ludlam","year":"2011","journal-title":"Adv Ther"},{"key":"10.1378\/chest.13-0382_bib19","doi-asserted-by":"crossref","first-page":"73","DOI":"10.2147\/PPA.S20783","article-title":"Lanreotide depot deep subcutaneous injection: a new method of delivery and its associated benefits","volume":"6","author":"Carmichael","year":"2012","journal-title":"Patient Prefer Adherence"},{"issue":"1","key":"10.1378\/chest.13-0382_bib20","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1210\/jc.2008-1008","article-title":"Treatment of pituitary-dependent Cushing's disease with the multireceptor ligand somatostatin analog pasireotide (SOM230): a multicenter, phase II trial","volume":"94","author":"Boscaro","year":"2009","journal-title":"J Clin Endocrinol Metab"},{"issue":"2","key":"10.1378\/chest.13-0382_bib21","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1210\/jc.2003-031052","article-title":"A single-dose comparison of the acute effects between the new somatostatin analog SOM230 and octreotide in acromegalic patients","volume":"89","author":"van der Hoek","year":"2004","journal-title":"J Clin Endocrinol Metab"},{"issue":"3","key":"10.1378\/chest.13-0382_bib22","doi-asserted-by":"crossref","first-page":"922","DOI":"10.1002\/hep.21907","article-title":"Prevention and management of gastroesophageal varices and variceal hemorrhage in cirrhosis","volume":"46","author":"Garcia-Tsao","year":"2007","journal-title":"Hepatology"},{"issue":"4","key":"10.1378\/chest.13-0382_bib23","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1053\/jhep.2001.23054","article-title":"A meta-analysis of endoscopic variceal ligation for primary prophylaxis of esophageal variceal bleeding","volume":"33","author":"Imperiale","year":"2001","journal-title":"Hepatology"},{"issue":"9","key":"10.1378\/chest.13-0382_bib24","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1056\/NEJMra0901512","article-title":"Management of varices and variceal hemorrhage in cirrhosis [published correction appears in N Engl J Med. 2011;364(5):490","volume":"362","author":"Garcia-Tsao","year":"2010","journal-title":"N Engl J Med"},{"issue":"3","key":"10.1378\/chest.13-0382_bib25","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1016\/S0168-8278(99)80035-X","article-title":"A predictive model for failure to control bleeding during acute variceal haemorrhage","volume":"31","author":"Ben-Ari","year":"1999","journal-title":"J Hepatol"},{"issue":"1","key":"10.1378\/chest.13-0382_bib26","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1055\/s-0032-1301734","article-title":"Acute variceal bleeding","volume":"33","author":"Garc\u00eda-Pag\u00e1n","year":"2012","journal-title":"Semin Respir Crit Care Med"},{"issue":"10","key":"10.1378\/chest.13-0382_bib27","doi-asserted-by":"crossref","first-page":"1710","DOI":"10.1007\/s00134-010-1954-x","article-title":"Transfusion-related acute lung injury in ICU patients admitted with gastrointestinal bleeding","volume":"36","author":"Benson","year":"2010","journal-title":"Intensive Care Med"},{"issue":"3","key":"10.1378\/chest.13-0382_bib28","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1002\/hep.20339","article-title":"Improved survival after variceal bleeding in patients with cirrhosis over the past two decades","volume":"40","author":"Carbonell","year":"2004","journal-title":"Hepatology"},{"issue":"9","key":"10.1378\/chest.13-0382_bib29","article-title":"Antibiotic prophylaxis for cirrhotic patients with upper gastrointestinal bleeding","volume":"9","author":"Chavez-Tapia","year":"2010","journal-title":"Cochrane Database Syst Rev"},{"issue":"4","key":"10.1378\/chest.13-0382_bib30","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1002\/hep.1840110421","article-title":"Hemodynamic effects of glucagon in portal hypertension","volume":"11","author":"Silva","year":"1990","journal-title":"Hepatology"},{"issue":"1","key":"10.1378\/chest.13-0382_bib31","first-page":"134","article-title":"Octreotide blunts postprandial splanchnic hyperemia in cirrhotic patients: a double-blind randomized echo-Doppler study","volume":"21","author":"Buonamico","year":"1995","journal-title":"Hepatology"},{"issue":"3","key":"10.1378\/chest.13-0382_bib32","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1053\/jhep.2002.31354","article-title":"Endoscopic treatment versus endoscopic plus pharmacologic treatment for acute variceal bleeding: a meta-analysis","volume":"35","author":"Ba\u00f1ares","year":"2002","journal-title":"Hepatology"},{"issue":"8991-8992","key":"10.1378\/chest.13-0382_bib33","doi-asserted-by":"crossref","first-page":"1666","DOI":"10.1016\/S0140-6736(95)92840-5","article-title":"Prospective randomised study of effect of octreotide on rebleeding from oesophageal varices after endoscopic ligation","volume":"346","author":"Sung","year":"1995","journal-title":"Lancet"},{"issue":"73","key":"10.1378\/chest.13-0382_bib34","first-page":"195","article-title":"Octreotide for esophageal variceal bleeding treated with endoscopic sclerotherapy: a randomized, placebo-controlled trial","volume":"54","author":"Morales","year":"2007","journal-title":"Hepatogastroenterology"},{"issue":"4","key":"10.1378\/chest.13-0382_bib35","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1016\/j.jhep.2006.05.016","article-title":"A randomized controlled trial comparing ligation and sclerotherapy as emergency endoscopic treatment added to somatostatin in acute variceal bleeding","volume":"45","author":"Villanueva","year":"2006","journal-title":"J Hepatol"},{"issue":"3","key":"10.1378\/chest.13-0382_bib36","article-title":"Somatostatin analogues for acute bleeding oesophageal varices","volume":"3","author":"G\u00f8tzsche","year":"2008","journal-title":"Cochrane Database Syst Rev"},{"issue":"3","key":"10.1378\/chest.13-0382_bib37","article-title":"Emergency sclerotherapy versus vasoactive drugs for bleeding oesophageal varices in cirrhotic patients","volume":"17","author":"D'Amico","year":"2010","journal-title":"Cochrane Database Syst Rev"},{"issue":"11","key":"10.1378\/chest.13-0382_bib38","doi-asserted-by":"crossref","first-page":"1267","DOI":"10.1111\/j.1365-2036.2012.05088.x","article-title":"Meta-analysis: vasoactive medications for the management of acute variceal bleeds","volume":"35","author":"Wells","year":"2012","journal-title":"Aliment Pharmacol Ther"},{"issue":"1","key":"10.1378\/chest.13-0382_bib39","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1056\/NEJM200101043440104","article-title":"Early administration of vapreotide for variceal bleeding in patients with cirrhosis","volume":"344","author":"Cal\u00e8s","year":"2001","journal-title":"N Engl J Med"},{"issue":"2","key":"10.1378\/chest.13-0382_bib40","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1067\/mem.2000.108183","article-title":"Octreotide: an antidote for sulfonylurea-induced hypoglycemia","volume":"36","author":"McLaughlin","year":"2000","journal-title":"Ann Emerg Med"},{"key":"10.1378\/chest.13-0382_bib41","series-title":"Mol Clin Environ Toxicol","first-page":"397","article-title":"Drugs and pharmaceuticals: management of intoxication and antidotes","author":"Smith","year":"2010"},{"issue":"9","key":"10.1378\/chest.13-0382_bib42","doi-asserted-by":"crossref","first-page":"795","DOI":"10.3109\/15563650.2012.734626","article-title":"Octreotide for the treatment of sulfonylurea poisoning","volume":"50","author":"Glatstein","year":"2012","journal-title":"Clin Toxicol"},{"issue":"2","key":"10.1378\/chest.13-0382_bib43","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1016\/j.clon.2004.06.016","article-title":"The successful treatment of chylous effusions in malignant disease with octreotide","volume":"17","author":"Mincher","year":"2005","journal-title":"Clin Oncol (R Coll Radiol)"},{"issue":"3","key":"10.1378\/chest.13-0382_bib44","doi-asserted-by":"crossref","first-page":"e63","DOI":"10.1016\/j.ijcard.2008.12.210","article-title":"Octreotide therapy in two children with intractable postoperative chylothorax","volume":"146","author":"Hung","year":"2011","journal-title":"Int J Cardiol"},{"issue":"4","key":"10.1378\/chest.13-0382_bib45","doi-asserted-by":"crossref","first-page":"e151","DOI":"10.1111\/j.1651-2227.2011.02529.x","article-title":"Octreotide as therapeutic option for congenital idiopathic chylothorax: a case series","volume":"101","author":"Shah","year":"2012","journal-title":"Acta Paediatr"},{"issue":"3","key":"10.1378\/chest.13-0382_bib46","first-page":"617","article-title":"Terlipressin vs. octreotide in bleeding esophageal varices as an adjuvant therapy with endoscopic band ligation: a randomized double-blind placebo-controlled trial","volume":"104","author":"Abid","year":"2009","journal-title":"Am J Gastroenterol"},{"issue":"4","key":"10.1378\/chest.13-0382_bib47","doi-asserted-by":"crossref","first-page":"946","DOI":"10.1053\/gast.2001.22451","article-title":"Octreotide for acute esophageal variceal bleeding: a meta-analysis","volume":"120","author":"Corley","year":"2001","journal-title":"Gastroenterology"},{"issue":"2","key":"10.1378\/chest.13-0382_bib48","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1586\/17474124.2.2.185","article-title":"Vapreotide acetate for the treatment of esophageal variceal bleeding","volume":"2","author":"Cal\u00e8s","year":"2008","journal-title":"Expert Rev Gastroenterol Hepatol"},{"issue":"4 suppl 1","key":"10.1378\/chest.13-0382_bib49","first-page":"A799","article-title":"Meta-analysis of early combination of vapreotide to endoscopic treatment in variceal bleeding","volume":"132","author":"Platt","year":"2007","journal-title":"Gastroenterology"},{"issue":"1","key":"10.1378\/chest.13-0382_bib50","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/0016-5085(93)90031-7","article-title":"Incidence, predictive factors, and prognosis of the hepatorenal syndrome in cirrhosis with ascites","volume":"105","author":"Gin\u00e8s","year":"1993","journal-title":"Gastroenterology"},{"issue":"1","key":"10.1378\/chest.13-0382_bib51","first-page":"164","article-title":"Definition and diagnostic criteria of refractory ascites and hepatorenal syndrome in cirrhosis. International Ascites Club","volume":"23","author":"Arroyo","year":"1996","journal-title":"Hepatology"},{"issue":"9398","key":"10.1378\/chest.13-0382_bib52","doi-asserted-by":"crossref","first-page":"1819","DOI":"10.1016\/S0140-6736(03)14903-3","article-title":"Hepatorenal syndrome","volume":"362","author":"Gin\u00e8s","year":"2003","journal-title":"Lancet"},{"issue":"suppl 1","key":"10.1378\/chest.13-0382_bib53","doi-asserted-by":"crossref","first-page":"S69","DOI":"10.1016\/S0168-8278(03)00007-2","article-title":"Ascites and hepatorenal syndrome in cirrhosis: pathophysiological basis of therapy and current management","volume":"38","author":"Arroyo","year":"2003","journal-title":"J Hepatol"},{"issue":"2","key":"10.1378\/chest.13-0382_bib54","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1002\/hep.20766","article-title":"Circulatory function and hepatorenal syndrome in cirrhosis","volume":"42","author":"Ruiz-del-Arbol","year":"2005","journal-title":"Hepatology"},{"issue":"10","key":"10.1378\/chest.13-0382_bib55","doi-asserted-by":"crossref","first-page":"1196","DOI":"10.1592\/phco.29.10.1196","article-title":"Treatment of hepatorenal syndrome","volume":"29","author":"Kiser","year":"2009","journal-title":"Pharmacotherapy"},{"issue":"5","key":"10.1378\/chest.13-0382_bib56","doi-asserted-by":"crossref","first-page":"1026","DOI":"10.1016\/S0168-8278(97)80111-0","article-title":"Effect of octreotide on systemic, central, and splanchnic haemodynamics in cirrhosis","volume":"26","author":"M\u00f8ller","year":"1997","journal-title":"J Hepatol"},{"issue":"1","key":"10.1378\/chest.13-0382_bib57","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1016\/S0168-8278(99)80025-7","article-title":"Octreotide in the treatment of the hepatorenal syndrome in cirrhotic patients [Letter]","volume":"30","author":"Kaffy","year":"1999","journal-title":"J Hepatol"},{"issue":"9","key":"10.1378\/chest.13-0382_bib58","doi-asserted-by":"crossref","first-page":"1813","DOI":"10.1093\/ndt\/gfh930","article-title":"Vasopressin, not octreotide, may be beneficial in the treatment of hepatorenal syndrome: a retrospective study","volume":"20","author":"Kiser","year":"2005","journal-title":"Nephrol Dial Transplant"},{"issue":"4","key":"10.1378\/chest.13-0382_bib59","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1111\/j.1572-0241.2005.40899.x","article-title":"The effects of chronic treatment with octreotide versus octreotide plus midodrine on systemic hemodynamics and renal hemodynamics and function in nonazotemic cirrhotic patients with ascites","volume":"100","author":"Kalambokis","year":"2005","journal-title":"Am J Gastroenterol"},{"issue":"1","key":"10.1378\/chest.13-0382_bib60","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1053\/jhep.2003.50276","article-title":"Octreotide in hepatorenal syndrome: a randomized, double-blind, placebo-controlled, crossover study","volume":"38","author":"Pomier-Layrargues","year":"2003","journal-title":"Hepatology"},{"issue":"4","key":"10.1378\/chest.13-0382_bib61","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1002\/hep.510280407","article-title":"Acute effects of the oral administration of midodrine, an alpha-adrenergic agonist, on renal hemodynamics and renal function in cirrhotic patients with ascites","volume":"28","author":"Angeli","year":"1998","journal-title":"Hepatology"},{"issue":"6","key":"10.1378\/chest.13-0382_bib62","doi-asserted-by":"crossref","first-page":"1690","DOI":"10.1002\/hep.510290629","article-title":"Reversal of type 1 hepatorenal syndrome with the administration of midodrine and octreotide","volume":"29","author":"Angeli","year":"1999","journal-title":"Hepatology"},{"issue":"3","key":"10.1378\/chest.13-0382_bib63","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1007\/s10620-006-9312-0","article-title":"Octreotide\/Midodrine therapy significantly improves renal function and 30-day survival in patients with type 1 hepatorenal syndrome","volume":"52","author":"Esrailian","year":"2007","journal-title":"Dig Dis Sci"},{"issue":"7","key":"10.1378\/chest.13-0382_bib64","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1097\/MCG.0b013e318188947c","article-title":"Combination treatment with octreotide, midodrine, and albumin improves survival in patients with type 1 and type 2 hepatorenal syndrome","volume":"43","author":"Skagen","year":"2009","journal-title":"J Clin Gastroenterol"},{"issue":"1","key":"10.1378\/chest.13-0382_bib65","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1002\/hep.20262","article-title":"Midodrine, octreotide, albumin, and TIPS in selected patients with cirrhosis and type 1 hepatorenal syndrome","volume":"40","author":"Wong","year":"2004","journal-title":"Hepatology"},{"issue":"2","key":"10.1378\/chest.13-0382_bib66","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1016\/j.emc.2007.02.010","article-title":"Emergency management of oral hypoglycemic drug toxicity","volume":"25","author":"Rowden","year":"2007","journal-title":"Emerg Med Clin North Am"},{"issue":"2","key":"10.1378\/chest.13-0382_bib67","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1007\/s13181-010-0064-z","article-title":"Octreotide's role in the management of sulfonylurea-induced hypoglycemia","volume":"6","author":"Dougherty","year":"2010","journal-title":"J Med Toxicol"},{"issue":"4","key":"10.1378\/chest.13-0382_bib68","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1016\/j.annemergmed.2007.06.493","article-title":"Comparison of octreotide and standard therapy versus standard therapy alone for the treatment of sulfonylurea-induced hypoglycemia","volume":"51","author":"Fasano","year":"2008","journal-title":"Ann Emerg Med"},{"issue":"4","key":"10.1378\/chest.13-0382_bib69","first-page":"233","article-title":"Hypoglycaemia and counterregulatory hormone responses in severe falciparum malaria: treatment with Sandostatin","volume":"86","author":"Phillips","year":"1993","journal-title":"Q J Med"},{"issue":"7","key":"10.1378\/chest.13-0382_bib70","doi-asserted-by":"crossref","first-page":"867","DOI":"10.4065\/80.7.867","article-title":"Etiology of chylothorax in 203 patients","volume":"80","author":"Doerr","year":"2005","journal-title":"Mayo Clin Proc"},{"issue":"6","key":"10.1378\/chest.13-0382_bib71","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1055\/s-0030-1269834","article-title":"Chylothorax and cholesterol pleural effusion","volume":"31","author":"Huggins","year":"2010","journal-title":"Semin Respir Crit Care Med"},{"issue":"4","key":"10.1378\/chest.13-0382_bib72","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1097\/01.mcp.0000230629.73139.26","article-title":"Octreotide and chylothorax","volume":"12","author":"Kalomenidis","year":"2006","journal-title":"Curr Opin Pulm Med"},{"issue":"1","key":"10.1378\/chest.13-0382_bib73","first-page":"21","article-title":"Somatostatin receptors SSTR2 and SSTR5 are expressed in the human thoracic duct","volume":"44","author":"Jiang","year":"2011","journal-title":"Lymphology"},{"issue":"5","key":"10.1378\/chest.13-0382_bib74","doi-asserted-by":"crossref","first-page":"1864","DOI":"10.1016\/j.athoracsur.2005.04.048","article-title":"Postoperative chylothorax after cardiothoracic surgery in children","volume":"80","author":"Chan","year":"2005","journal-title":"Ann Thorac Surg"},{"issue":"10","key":"10.1378\/chest.13-0382_bib75","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1097\/MEG.0b013e328349aa2d","article-title":"Idiopathic chylous ascites treated with total parenteral nutrition and octreotide. A case report and review of the literature","volume":"23","author":"Yildirim","year":"2011","journal-title":"Eur J Gastroenterol Hepatol"}],"container-title":["Chest"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0012369215487070?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0012369215487070?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,15]],"date-time":"2025-09-15T07:22:40Z","timestamp":1757920960000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0012369215487070"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,12]]},"references-count":75,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2013,12]]}},"alternative-id":["S0012369215487070"],"URL":"https:\/\/doi.org\/10.1378\/chest.13-0382","relation":{},"ISSN":["0012-3692"],"issn-type":[{"value":"0012-3692","type":"print"}],"subject":[],"published":{"date-parts":[[2013,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Octreotide","name":"articletitle","label":"Article Title"},{"value":"Chest","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1378\/chest.13-0382","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 The American College of Chest Physicians. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}